• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    7/30/2025$235.00 → $250.00Outperform
    Wedbush
    Amazon.com Inc.
    $AMZN
    7/29/2025$238.00 → $245.00Equal Weight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    7/29/2025$245.00 → $262.00Buy
    Stifel
    Amazon.com Inc.
    $AMZN
    7/28/2025$249.00 → $271.00Buy
    UBS
    Amazon.com Inc.
    $AMZN
    7/23/2025$248.00 → $265.00Buy
    BofA Securities
    Amazon.com Inc.
    $AMZN
    7/22/2025$220.00 → $265.00Buy
    Needham
    Amazon.com Inc.
    $AMZN
    7/21/2025$220.00 → $244.00Outperform
    Robert W. Baird
    Amazon.com Inc.
    $AMZN
    7/11/2025$240.00 → $255.00Overweight
    Analyst
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

      • Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an additional $20 million in a secured subordinated promissory note convertible to prepaid revenue share • Medtronic and Orchestra BioMed expand strategic collaboration to provide pathway for development of AVIM therapy-enabled leadless pacemakers NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to

      7/31/25 4:01:11 PM ET
      $LGND
      $MDT
      $OBIO
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Medicinal Chemicals and Botanical Products
    • Amazon.com Announces Second Quarter Results

      Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its second quarter ended June 30, 2025. Net sales increased 13% to $167.7 billion in the second quarter, compared with $148.0 billion in second quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with second quarter 2024. North America segment sales increased 11% year-over-year to $100.1 billion. International segment sales increased 16% year-over-year to $36.8 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 17.5% year-over-year to $30.9 billion.

      7/31/25 4:01:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Ford Reports Second Quarter 2025 Financial Results

      Ford Motor Company (NYSE:F) today reported second quarter 2025 financial results and reinstated full-year 2025 guidance. The company also declared a third-quarter regular dividend of 15 cents per share, payable on Sept. 2 to shareholders of record at the close of business on Aug. 11. Visit the company's Investor Relations website at shareholder.ford.com to view the earnings release, earnings presentation and other supporting material. At 5:00 p.m. ET, Ford and Ford Motor Credit Company management will hold a conference call to discuss these financial results. For the webcast, click here. Representatives of the investment community will be able to ask questions on the call. The webcast w

      7/30/25 4:05:00 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Gerberding Julie L.

      4 - MCKESSON CORP (0000927653) (Issuer)

      7/31/25 6:38:18 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Director Ozan Kevin M

      4 - MCKESSON CORP (0000927653) (Issuer)

      7/31/25 6:33:37 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Director Doughtie Lynne M

      4 - MCKESSON CORP (0000927653) (Issuer)

      7/31/25 6:33:16 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wedbush reiterated coverage on Amazon with a new price target

      Wedbush reiterated coverage of Amazon with a rating of Outperform and set a new price target of $250.00 from $235.00 previously

      7/30/25 8:08:23 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Stifel reiterated coverage on Amazon with a new price target

      Stifel reiterated coverage of Amazon with a rating of Buy and set a new price target of $262.00 from $245.00 previously

      7/29/25 8:13:50 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Wells Fargo reiterated coverage on Amazon with a new price target

      Wells Fargo reiterated coverage of Amazon with a rating of Equal Weight and set a new price target of $245.00 from $238.00 previously

      7/29/25 8:13:50 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • March 11, 2025 - FDA Roundup: March 11, 2025

      For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

      3/13/25 3:14:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • November 14, 2023 - FDA Roundup: November 14, 2023

      For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

      11/14/23 3:26:18 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    See more
    • Amazon.com Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - AMAZON COM INC (0001018724) (Filer)

      7/31/25 4:13:17 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form S-8 filed by Ford Motor Company

      S-8 - FORD MOTOR CO (0000037996) (Filer)

      7/30/25 7:37:56 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form 10-Q filed by Ford Motor Company

      10-Q - FORD MOTOR CO (0000037996) (Filer)

      7/30/25 7:23:39 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/13/25 4:10:38 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Director Hundzinski Ronald T bought $133,350 worth of shares (5,000 units at $26.67), increasing direct ownership by 38% to 18,006 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/12/25 4:06:43 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • SVP, General Manager, Europe Stocker Thomas bought $8,011 worth of shares (321 units at $24.96), increasing direct ownership by 2% to 20,638 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      4/29/25 8:46:29 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    See more
    • Amazon.com Announces Second Quarter Results

      Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its second quarter ended June 30, 2025. Net sales increased 13% to $167.7 billion in the second quarter, compared with $148.0 billion in second quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with second quarter 2024. North America segment sales increased 11% year-over-year to $100.1 billion. International segment sales increased 16% year-over-year to $36.8 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 17.5% year-over-year to $30.9 billion.

      7/31/25 4:01:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Ford Reports Second Quarter 2025 Financial Results

      Ford Motor Company (NYSE:F) today reported second quarter 2025 financial results and reinstated full-year 2025 guidance. The company also declared a third-quarter regular dividend of 15 cents per share, payable on Sept. 2 to shareholders of record at the close of business on Aug. 11. Visit the company's Investor Relations website at shareholder.ford.com to view the earnings release, earnings presentation and other supporting material. At 5:00 p.m. ET, Ford and Ford Motor Credit Company management will hold a conference call to discuss these financial results. For the webcast, click here. Representatives of the investment community will be able to ask questions on the call. The webcast w

      7/30/25 4:05:00 PM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share

      The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025. "McKesson continues our long-standing track record of returning capital to shareholders, marking our ninth consecutive annual dividend increase," said Brian Tyler, chief executive officer. "These actions reflect our confidence in the strength of our business and reinforces our commitment to delivering long-term value to shareholders." About McKesson Corporation McKesson Corporation is a diversified heal

      7/30/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    See more
    • ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation

      HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility's Peak Load Reduction program, a first in the nine-year history of the utility's peak load reduction programs. Designed to alleviate strain on the power grid during summer months, the initiative will leverage ChargeScape's AI-powered technology platform and aims to intelligently integrate more than 4,000 BMW EV drivers and 2,200 Ford EV drivers into the power grid. Participating customers will receive financial incentives for helping to support grid stability and community

      7/22/25 7:00:00 AM ET
      $F
      Auto Manufacturing
      Consumer Discretionary
    • Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

      GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

      7/8/25 8:45:00 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Medtronic Board appoints Dr. Joon Lee as a new director

      GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

      6/23/25 4:15:00 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Subject)

      11/8/24 4:33:15 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

      11/7/24 5:23:12 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

      SC 13G/A - Medtronic plc (0001613103) (Subject)

      2/13/24 5:09:43 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care